Keel Pharmaceuticals, Inc. is an emerging biopharmaceutical company that is developing new therapies for treating type 1 diabetes, lupus, scleroderma and other autoimmune diseases. Keel's technology is based on the identification of specific protein processing and signaling defects in the...
Your Rating
You must submit at least one review.
Review successfully posted.
You will shortly receive an email to confirm your review.
Currently no review was submitted for this company. Share your experiences with this company!